25 May 2013
Keywords: new, data, xenova, ta-cd, cocaine, vaccine, uk
Article | 21 June 2004
The UK's Xenova has released findings from two dose-escalation Phase II studies of its TA-CD, a vaccine with potential utility ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.